Literature DB >> 32820492

Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia.

Orit H Lesman-Segev1, Lauren Edwards1, Gil D Rabinovici1,2,3.   

Abstract

The clinical diagnosis of chronic traumatic encephalopathy (CTE) is challenging due to heterogeneous clinical presentations and overlap with other neurodegenerative dementias. Depending on the clinical presentation, the differential diagnosis of CTE includes Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), Parkinson's disease, amyotrophic lateral sclerosis, primary mood disorders, posttraumatic stress disorder, and psychotic disorders. The aim of this article is to compare the clinical aspects, genetics, fluid biomarkers, imaging, treatment, and pathology of CTE to those of AD and bvFTD. A detailed clinical evaluation, neurocognitive assessment, and structural brain imaging can inform the differential diagnosis, while molecular biomarkers can help exclude underlying AD pathology. Prospective studies that include clinicopathological correlations are needed to establish tools that can more accurately determine the cause of neuropsychiatric decline in patients at risk for CTE. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32820492     DOI: 10.1055/s-0040-1715134

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  2 in total

Review 1.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

2.  Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.

Authors:  Michael L Alosco; Megan L Mariani; Charles H Adler; Laura J Balcer; Charles Bernick; Rhoda Au; Sarah J Banks; William B Barr; Sylvain Bouix; Robert C Cantu; Michael J Coleman; David W Dodick; Lindsay A Farrer; Yonas E Geda; Douglas I Katz; Inga K Koerte; Neil W Kowall; Alexander P Lin; Daniel S Marcus; Kenneth L Marek; Michael D McClean; Ann C McKee; Jesse Mez; Joseph N Palmisano; Elaine R Peskind; Yorghos Tripodis; Robert W Turner; Jennifer V Wethe; Jeffrey L Cummings; Eric M Reiman; Martha E Shenton; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2021-08-12       Impact factor: 8.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.